Announcement of the list of top 100 pharmacies and drug approvals in the country

The Ministry of Commerce authoritatively released the list of the top 100 national pharmaceutical retail and wholesale enterprises in 2020
.

Top 100 pharmacies in sales, National University pharmacy ranked first with 21.
6 billion yuan

Recently, the Ministry of Commerce released the "Statistical Analysis Report on the Operation of the Pharmaceutical Circulation Industry in 2020" (hereinafter referred to as the "Report"), which carried out some analysis and forecasts on the pharmaceutical circulation industry in China
.

The "Report" shows that in 2020, China's pharmaceutical retail market will be 511.
9 billion yuan, a year-on-year growth of 10.
1% after deducting incomparable factors, and the growth rate will accelerate by 0.
2% year-on-year
.

In addition, the "Report" also announced the top 100 drug retail companies in total sales in 2020, which are basically chain pharmacies.
Guoda pharmacies have sales of approximately 21.
6 billion yuan, ranking first; Dashenlin (15.
3 billion yuan) and ordinary people (148 100 million yuan), Yifeng (13.
6 billion yuan), and Yixintang (12.
8 billion yuan) ranked 2-5
.

China's top 100 pharmaceutical batches topped the list, with a core revenue of 480.
6 billion yuan

As of the end of 2020, there were 13,100 pharmaceutical wholesale companies nationwide.
From the perspective of market share, the concentration of pharmaceutical wholesale companies has increased
.

In 2020, the top 100 pharmaceutical wholesale companies' main business income accounted for 73.
7% of the total national pharmaceutical market during the same period, a year-on-year increase of 0.
4%
.

Among them, the main business income of 4 leading national companies accounted for 42.
6% of the total national pharmaceutical market in the same period, an increase of 1.
6 percentage points year-on-year; the top 10 accounted for 55.
2%, an increase of 3.
2 percentage points year-on-year; the top 20 accounted for 63.
5%, an increase year-on-year 2.
0 percentage points; the top 50 accounted for 70.
0%, an increase of 0.
9 percentage points year-on-year
.

Among the top 100 main business revenues of pharmaceutical wholesale companies in 2020 released by the "Report", China Pharmaceuticals’ main business revenue is about 480.
6 billion yuan, ranking first, Shanghai Pharmaceuticals (168.
2 billion yuan), China Resources Pharmaceuticals (151.
1 billion yuan) ), Jointown (110.
8 billion yuan), China Medicine Chongqing Pharmaceutical Consortium (84.
4 billion yuan) ranked 2-5
.

Top 100 pharmacies, 18% stores account for 35% of the market

According to the "Report", the total sales of the top 100 pharmaceutical retail companies in 2020 will be 180.
6 billion yuan, accounting for 35.
3% of the total retail market in the country, an increase of 0.
4% year-on-year
.

In addition, according to industry estimates, the number of retail pharmacies in the top 100 retail pharmacies in the country accounted for 18% of the total number of stores
.

From 2016 to 2020, the top 100 pharmaceutical retail companies accounted for an increasing market share.
The market share of 35.
3% in 2020 has increased by 6.
2 percentage points compared with 2016
.

Although the industry concentration is increasing, the degree is different in each region
.

Some insiders pointed out that there will be more top 100 chain stores in big provinces with pharmacies, such as Guangdong, Shandong, and Zhejiang
.

The report stated that the sales of pharmaceutical retail companies rose steadily, and the growth rate was higher than the overall level of the circulation industry
.

1.
During the epidemic, pharmacies have become a place for people to purchase medical protection materials and related drugs needed for epidemic prevention.

Important place
.

2.
Pharmaceutical retail companies adjusted the category structure in a timely manner to meet market demand, and the sales of household medical devices and general health care products increased significantly
.

3.
Multi-format online and offline value-added services such as B2C, O2O and "Internet+" have driven the continued growth of retail market sales
.

4.
Many retail companies take the initiative to participate in the centralized procurement of local medicines, or adjust product prices in a timely manner to stabilize the source of customers, and strengthen the coordinated development of the upstream supply chain to maintain the retail terminal market
.

Integration of online and offline development, an important new growth point in the industry

According to the "Report", in 2020, the total sales of direct-reported pharmaceutical e-commerce companies will reach 177.
8 billion yuan (including the transaction volume of third-party transaction service platforms), accounting for 7.
4% of the total scale of the national pharmaceutical market during the same period
.

The "Report" emphasizes that e-commerce companies are currently cooperating with offline physical pharmacies, accelerating the integration of online and offline development, realizing the operation mode of "fetching from online ordering stores" and "delivering online ordering stores" to ensure the safety of medicines.